REGENXBIO (RGNX)
Develops one-time AAV gene therapies while licensing its NAV vector platform.
$7.47
vs last close−0.68 (−8.33%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 43 days
EPS estimate
−$1.21
Revenue estimate
$15.9M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$1.01$0.12−$1.38−$1.20−$1.30−$1.72$0.43Pending
Estimate−$1.27$0.41−$1.13−$1.38−$1.01−$1.36$0.08−$1.21
Surprise+20.5%−70.7%−22.1%+13.0%−28.7%−26.5%+446.2%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$21.2M$89.0M$21.4M$29.7M$30.3M$6.4M$108.0MPending
Estimate$23.7M$105.4M$110.0M$59.3M$44.0M$25.8M$97.6M$15.9M
Surprise−10.5%−15.5%−80.6%−49.8%−31.0%−75.3%+10.6%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.49 | — | — |
| Sep 2028 | −$0.43 | — | — |
| Jun 2028 | −$0.90 | — | — |
| Mar 2028 | −$0.72 | — | — |
| Dec 2027 | −$0.97 | — | — |
| Sep 2027 | −$0.59 | — | — |
| Jun 2027 | −$1.14 | — | — |
| Mar 2027 | −$1.23 | — | — |
| Dec 2026 | −$0.91 | — | — |
| Nov 2026 | −$1.21 | — | — |
| Aug 2026 | $0.08 | $0.43 | +446.2% |
| May 2026 | −$1.36 | −$1.72 | −26.5% |
| Mar 2026 | −$1.01 | −$1.30 | −28.7% |
| Nov 2025 | −$1.38 | −$1.20 | +13.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Sep 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.49 | — | — | $63.4M | — | — | — |
| Sep 2028 | −$0.43 | — | — | $48.1M | — | — | — |
| Jun 2028 | −$0.90 | — | — | $43.7M | — | — | — |
| Mar 2028 | −$0.72 | — | — | $26.5M | — | — | — |
| Dec 2027 | −$0.97 | — | — | $13.7M | — | — | — |
| Sep 2027 | −$0.59 | — | — | $40.0M | — | — | — |
| Jun 2027 | −$1.14 | — | — | $19.1M | — | — | — |
| Mar 2027 | −$1.23 | — | — | $13.4M | — | — | — |
| Dec 2026 | −$0.91 | — | — | $35.8M | — | — | — |
| Nov 5, 2026 | −$1.21 | — | — | $15.9M | — | — | — |
| Aug 6, 2026 | $0.08 | $0.43 | +446.2% | $97.6M | $108.0M | +10.6% | +7.4% |
| May 14, 2026 | −$1.36 | −$1.72 | −26.5% | $25.8M | $6.4M | −75.3% | −37.8% |
| Mar 5, 2026 | −$1.01 | −$1.30 | −28.7% | $44.0M | $30.3M | −31.0% | −4.6% |
| Nov 6, 2025 | −$1.38 | −$1.20 | +13.0% | $59.3M | $29.7M | −49.8% | −3.8% |
| Aug 7, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 13, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 1, 2024 | |||||||
| May 8, 2024 | |||||||
| Feb 27, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 2, 2023 | |||||||
| May 3, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 3, 2022 | |||||||
| May 4, 2022 | |||||||
| Mar 1, 2022 | |||||||
| Nov 2, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 5, 2021 | |||||||
| Mar 1, 2021 | |||||||
| Nov 4, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 7, 2020 | |||||||
| Feb 26, 2020 | |||||||
| Nov 5, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 7, 2019 | |||||||
| Feb 27, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 8, 2018 | |||||||
| Mar 6, 2018 | |||||||
| Nov 8, 2017 | |||||||
| Aug 8, 2017 | |||||||
| May 9, 2017 | |||||||
| Mar 7, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Aug 9, 2016 | |||||||
| May 5, 2016 | |||||||
| Mar 3, 2016 | |||||||
| Nov 5, 2015 | |||||||
| Sep 17, 2015 |